The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
People with Type 1 or Type 2 diabetes make up over a quarter of those waiting for an organ transplant in Wisconsin.
Height has been linked to an increased risk of certain cancers, including pancreatic, uterine, and breast cancer, due to ...
Wade said on his podcast that he had the surgery in 2023.
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.
The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...